Asha Nayak

Associate Professor

  • 216 Citations
  • 10 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Asha Nayak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Neoplasms Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Cytotoxic T-Lymphocytes Medicine & Life Sciences
Granzymes Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences
Bone Marrow Examination Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Cytochrome P-450 CYP2D6 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 216 Citations
  • 10 h-Index
  • 11 Article
  • 1 Review article

Type i interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

Lu, C., Klement, J. D., Ibrahim, M. L., Xiao, W., Redd, P. S., Nayak, A., Zhou, G. & Liu, K., Jun 22 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 157.

Research output: Contribution to journalArticle

Open Access
Granzymes
Cytotoxic T-Lymphocytes
Interferons
Growth
Neoplasms
21 Citations (Scopus)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Nayak-Kapoor, A., Hao, Z., Sadek, R., Dobbins, R., Marshall, L., Vahanian, N. N., Jay Ramsey, W., Kennedy, E., Mautino, M. R., Link, C. J., Lin, R. S., Royer-Joo, S., Liang, X., Salphati, L., Morrissey, K. M., Mahrus, S., McCall, B., Pirzkall, A., Munn, D. H., Janik, J. E. & 1 others, Khleif, S. N., Jun 20 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 61.

Research output: Contribution to journalArticle

Indoleamine-Pyrrole 2,3,-Dioxygenase
Kynurenine
Half-Life
Neoplasms
Tryptophan
19 Citations (Scopus)

SETD1B activates iNOS expression in myeloid-derived suppressor cells

Redd, P. S., Ibrahim, M. L., Klement, J. D., Sharman, S. K., Paschall, A. V., Yang, D., Nayak, A. & Liu, K., Jun 1 2017, In : Cancer Research. 77, 11, p. 2834-2843 10 p.

Research output: Contribution to journalArticle

Nitric Oxide Synthase Type II
Neoplasms
Myeloid Cells
Nitric Oxide
Myeloid-Derived Suppressor Cells
12 Citations (Scopus)

CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype

Paschall, A. V., Yang, D., Lu, C., Redd, P. S., Choi, J. H., Heaton, C. M., Lee, J. R., Nayak-Kapoor, A. & Liu, K., Jan 1 2016, In : Oncotarget. 7, 48, p. 78698-78712 15 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Fluorouracil
Colonic Neoplasms
Phenotype
Gene Expression
37 Citations (Scopus)

H3K9 trimethylation silences fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance

Paschall, A. V., Yang, D., Lu, C., Choi, J-H., Li, X., Liu, F., Figueroa, M., Oberlies, N. H., Pearce, C., Bollag, W. B., Nayak, A. & Liu, K., Aug 15 2015, In : Journal of Immunology. 195, 4, p. 1868-1882 15 p.

Research output: Contribution to journalArticle

Fluorouracil
Colon
Carcinoma
Immune Evasion
decitabine